NEUROPHET
Neurophet produces solutions based on Segengine, the companyโs own technology that automatically segments brain magnetic resonance (MR) images into 107 regions within a minute.
NEUROPHET
Industry:
Artificial Intelligence Machine Learning Medical Neuroscience Software
Founded:
2016-03-14
Address:
Gangneung, Kangwon-do, South Korea
Country:
South Korea
Website Url:
http://www.neurophet.com
Total Employee:
11+
Status:
Active
Total Funding:
7.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Font Awesome Apache
Similar Organizations
Mimica Automation
Mimica watches you work and learns to automate your most repetitive tasks.
Navina
Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.
Pateo
Pateo uses artificial intelligence to provide automobile solutions.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Tasq.ai
Tasq.ai is a computer software company in the AI field. Tasq.ai provides nextgen data solutions for AI at ultra scale.
TUNGEE
Tungee is a professional sales intelligence solution provider.
Yihang.ai
Yihang.ai manufactures autonomous driving systems.
Current Employees Featured
Founder
Investors List
FuturePlay
FuturePlay investment in Pre Seed Round - NEUROPHET
Official Site Inspections
http://www.neurophet.com Semrush global rank: 4.98 M Semrush visits lastest month: 1.69 K
- Host name: ec2-13-125-147-91.ap-northeast-2.compute.amazonaws.com
- IP address: 13.125.147.91
- Location: Incheon South Korea
- Latitude: 37.4562
- Longitude: 126.7288
- Timezone: Asia/Seoul
- Postal: 21539
More informations about "NEUROPHET"
Neurophet
๋ ์ํ ๋ถ์ผ์์ ๋ด๋กํ๋ง์ ์ ๋ฌธ์ฑ์ ๋ฐํ์ผ๋ก ์๋ฃ๊ณ์ ํ์ํ ์๋ฃจ์ ์ ์ ๊ณตํ์ฌ ๋ ์งํ์ผ๋ก ๊ณ ํต๋ฐ๋ ํ์๋ค์ ๋๊ฒ ์ต๋๋ค. ๋ด๋กํ SegEngine์ ๋ ์์ญ๋ณ ๊ตฌ์กฐ ์ธก์ ์ ์ํ ์ธ๊ณต์ง๋ฅ ๊ธฐ๋ฐ ๋ MRI ์์ ๋ถํ ๊ธฐ์ ๋ ฅ์ ๊ฐ์ถ๊ณ โฆSee details»
NEUROPHET - Crunchbase Company Profile & Funding
NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment. NEUROPHET may be growing as it has recently raised over $35 million, indicating a significant influx of capital that โฆSee details»
Neurophet Company Profile 2024: Valuation, Funding โฆ
Developer of a neuroscience simulation software designed to predict and investigate Alzheimer's stimulation effects.See details»
Neurophet, the first company in Korea, selected by Roche โฆ
Sep 5, 2023ย ยท Neurophet as selected for the program will collaborate on exploring joint commercialization opportunities together with Roche Diagnostics in Korea and beyond. โฆSee details»
Neurophet - LinkedIn
Overcome brain disorders with advanced neuroscience. | Neurophet has specialized in developing solutions for diagnosis support, treatment guides, and treatment devices targeting โฆSee details»
Neurophet Appoints CTO Donghyeon Kim as Co-CEO, Joining Jake โฆ
Nov 15, 2024ย ยท Neurophet, an artificial intelligence (AI) solution company for brain disease, newly appointed Donghyeon Kim, who is currently CTO (Chief Technology Officer), to serve as Co โฆSee details»
NEUROPHET - Funding, Financials, Valuation & Investors
NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment.See details»
FDA Clears AI-Powered MRI Software to Assess for โฆ
May 19, 2023ย ยท The Food and Drug Administration (FDA) has granted 510(k) clearance for Neurophet AQUA (Neurophet), an artificial intelligence (AI) software that may enhance the assessment of brain atrophy on magnetic resonance โฆSee details»
Neurophet secures โฉ20 billion in Series C funding to โฆ
Nov 7, 2023ย ยท Neurophet said Tuesday it has successfully secured 20 billion won ($15.3 million) in Series C investment in recognition of its brain image analysis technology and future growth potential.See details»
Neurophet Company Profile - Office Locations, Competitors, โฆ
Neurophet is a brain disease diagnostics company. It provides technology that automatically segments brain magnetic resonance (MR) images. The company aims to develop โฆSee details»
Neurophet - Products, Competitors, Financials, Employees, โฆ
Neurophet specializes in the development of solutions for brain diseases, operating in the healthcare and artificial intelligence sectors. Use the CB Insights Platform to explore โฆSee details»
Jake Junkil Been - Innovators Under 35
Neurophetโs mission is to contribute to overcoming brain disease through advanced neurotechnologies. Neurophet develops image-based diagnosis, treatment-planning software, โฆSee details»
Neurophet Appoints CTO Donghyeon Kim as Co-CEO, Joining Jake โฆ
SEOUL, South Korea, Nov. 15, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, newly appointed Donghyeon Kim, who is currently CTO โฆSee details»
Neurophet joins with AriBio to drive AI-powered Alzheimerโs โฆ
Oct 16, 2024ย ยท Neurophet will be working with AriBio for its global Phase III trial (NCT05531526) of AR1001, an oral treatment for Alzheimerโs disease, with both companies utilising the โฆSee details»
Neurophet - Overview, News & Similar companies | ZoomInfo.com
Nov 22, 2023ย ยท View Neurophet (www.neurophet.com) location in South Korea , revenue, industry and description. Find related and similar companies as well as employees by title and much โฆSee details»
Neurophet wins FDA nod for brain AI software, targets US expansion
3 days agoย ยท On the heels of U.S. FDA approval for Neurophet Aqua, an updated version of its artificial intelligence (AI)-based magnetic resonance imaging analysis software for the brain, โฆSee details»
Neurophet to participate BIO USAโฆ exploring global partnership โฆ
May 31, 2024ย ยท Neurophet will highlight its Imaging CRO (Contract Research Organization) service, which could be used in clinical trials for the treatment of Alzheimer's disease, during โฆSee details»
Evaluating brain volume segmentation accuracy and reliability of ...
Oct 18, 2024ย ยท In most brain regions, the Neurophet AQUA yielded a smaller average volume difference percentage (all < 10%) than FreeSurfer (all > 10%). The Neurophet AQUA exhibited โฆSee details»
Artificial intelligence-driven algorithm to detect and count cerebral ...
Dec 25, 2023ย ยท We present an algorithm which can detect CMBs and count the number of them, automatically and accurately. We employed datasets of both SWI and phase images, โฆSee details»
Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's โฆ
Oct 15, 2024ย ยท Neurophet has entered into an agreement with AriBio to participate in the global phase 3 clinical trial of AR1001, an oral treatment for Alzheimer's disease. Neurophet plays a โฆSee details»